FDA Inspection 1235117 — Luc M. Biedermann, M.D.
The FDA completed an inspection of Luc M. Biedermann, M.D. on Mar 1, 2024 in Zurich. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 1, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Zurich (Switzerland)
Additional Details
Clinical Investigator (CI)